作者：
Alexander P J,Vlaar [1]
;
Sanne,de Bruin [1]
;
Matthias,Busch [2]
;
Sjoerd A M E G,Timmermans [2]
;
Ingeborg E,van Zeggeren [3]
;
Rutger,Koning [3]
;
Liora,Ter Horst [3]
;
Esther B,Bulle [1]
;
Frank E H P,van Baarle [1]
;
Marcel C G,van de Poll [4]
;
E Marleen,Kemper [5]
;
Iwan C C,van der Horst [4]
;
Marcus J,Schultz [1]
;
Janneke,Horn [1]
;
Frederique,Paulus [1]
;
Lieuwe D,Bos [1]
;
W Joost,Wiersinga [6]
;
Martin,Witzenrath [7]
;
Simon,Rueckinger [8]
;
Korinna,Pilz [9]
;
Matthijs C,Brouwer [3]
;
Ren-Feng,Guo [10]
;
Leo,Heunks [11]
;
Pieter,van Paassen [2]
;
Niels C,Riedemann [9]
;
Diederik,van de Beek [3]
作者单位：
Department of Intensive Care, University of Amsterdam, Amsterdam UMC, Amsterdam, Netherlands.
[1]
Department of Immunology, Maastricht UMC, Maastricht, Netherlands.
[2]
Department of Neurology, Amsterdam Neuroscience, University of Amsterdam, Amsterdam UMC, Amsterdam, Netherlands.
[3]
Department of Intensive Care, Maastricht UMC, Maastricht, Netherlands.
[4]
Clinical Pharmacy, University of Amsterdam, Amsterdam UMC, Amsterdam, Netherlands.
[5]
Department of Infectious Diseases, University of Amsterdam, Amsterdam UMC, Amsterdam, Netherlands.
[6]
Department of Infectious Diseases and Respiratory Medicine, Division of Pulmonary Inflammation, Charité-Universitätsmedizin Berlin, Berlin, Germany.
[7]
Metronomia Clinical Research, Munich, Germany.
[8]
InflaRx, Jena, Germany.
[9]
InflaRx Pharmaceuticals, Ann Arbor, MI, USA.
[10]
Department of Intensive Care, Free University, Amsterdam UMC, Amsterdam, Netherlands.
[11]
DOI
10.1016/S2665-9913(20)30341-6
PMID
33015643
发布时间
2024-03-29
换一批
换一批
